Kross Ltd Approves Rs 63.6 Crore Capital Infusion

• Equity issuance: Rs 31.80 crore (15,00,000 shares) to non-promoters at Rs 212 per share.
• Warrants issuance: Rs 31.80 crore (15,00,000 warrants) to promoters at Rs 212 per share.

Reader Takeaway: The capital raise bolsters the balance sheet but introduces share dilution; monitor fund utilization strategy closely.

What just happened

Kross Ltd’s Board of Directors approved a preferential issue of equity shares and convertible warrants on August 31, 2026. The company intends to raise a total of Rs 63.60 crore. Non-promoter investors will receive 15 lakh equity shares, while promoters Sumeet Rai and Kunal Rai are set to receive 15 lakh warrants. The issue price for both instruments is fixed at Rs 212 per share.

Why this matters

This capital injection provides Kross Ltd with significant liquidity to fund operational requirements. While equity shares provide immediate capital, the warrants show continued commitment from promoters. For the warrants, 25% of the total price is payable upfront, with the remaining 75% due upon conversion within an 18-month window. This phased approach to capital infusion aims to support long-term growth initiatives.

Shareholder Voting Process

To finalize this transaction, the company has initiated a postal ballot. Remote e-voting is scheduled from September 1, 2026, to September 30, 2026. Mr. Sital Prasad Swain has been appointed as the scrutinizer to ensure transparency in the voting process.

Risks to watch

Investors should be mindful of the dilution effect on existing shareholding once these warrants are converted into equity. Furthermore, the company must effectively deploy these funds to justify the valuation and ensure long-term value creation. If warrant holders fail to exercise their options within the 18-month timeframe, the upfront payments will be forfeited.

What to track next

The outcome of the postal ballot is the immediate next step. Investors should wait for the formal voting results on September 30 to understand shareholder sentiment regarding this dilution and the company's future growth roadmap.